Arthritis, a widespread and debilitating inflammatory condition, affects millions globally and poses a significant treatment challenge, particularly in the search for interventions with minimal side effects. This study conducted a comprehensive investigation into the potential of Artemisia herba-alba (AHA), a medicinal plant, in addressing arthritis progression. (AHA), a plant deeply ingrained in Moroccan culinary traditions has long been utilized by locals for its anti-inflammatory, antibacterial, and analgesic properties. We explored the protective effects of AHA in a novel chronic arthritis model, induced by the combination of carrageenan (CGN) and incomplete Freund's adjuvant (IFA). Our findings revealed a significant reduction in arthritis progression, suggesting its potential as an anti-arthritic agent. Impressively, AHA exhibited no adverse effects on liver health, in contrast to indomethacin, a widely-used anti-inflammatory drug known for its hepatotoxicity. Furthermore, histological analysis of affected joints indicated the plant's ability to mitigate bone damage by reducing vascular and trabecular bone hyperplasia. It also resulted in a significant reduction in the number of osteoclasts, suggesting its potential to inhibit bone resorption and prevent further joint degradation. These findings highlight the therapeutic promise of AHA in managing chronic arthritis and preserving joint health. Further research is needed to explore its underlying mechanisms and clinical applications.